Heery Christopher Insider Trading Activity

Corporate InsiderCHIEF MEDICAL OFFICER · CIK 1789632

11

Total trades

$4.3M

Total volume

Jan 14, 2026

Last activity

ACLX

Arcellx, Inc.

Heery Christopher has been net-selling over the last 12 months with 0 purchases and 11 sales across 1 company.

ACLX is the most-traded position with 11 trades. The largest single transaction was a sale of ACLX for $1.2M on Sep 30, 2025.

Performance Scorecard

Forward stock performance after each transaction by Heery Christopher. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-3.7%18%11
90 days-5.9%73%11
120 days+9.3%88%8

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

ACLX · Arcellx, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Heery Christopher bought and sold ACLX.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Jan 14, 2026
ACLXSell5,882$68.51$403K−19.9%CHIEF MEDICAL OFFICER
Jan 13, 2026
ACLXSell7,437$65.51$487K−20.1%CHIEF MEDICAL OFFICER
Jan 12, 2026
ACLXSell6,131$64.15$393K−14.2%CHIEF MEDICAL OFFICER
Nov 17, 2025
ACLXSell340$90.00$31K−54.5%CHIEF MEDICAL OFFICER
Sep 30, 2025
ACLXSell14,204$81.46$1.2M−86.8%CHIEF MEDICAL OFFICER
Sep 30, 2025
ACLXSell5,300$80.55$427K−24.5%CHIEF MEDICAL OFFICER
Sep 30, 2025
ACLXSell1,530$82.20$126K−71.0%CHIEF MEDICAL OFFICER
Sep 29, 2025
ACLXSell73$80.16$6K−0.3%CHIEF MEDICAL OFFICER
Sep 26, 2025
ACLXSell12,396$80.12$993K−36.3%CHIEF MEDICAL OFFICER
Sep 19, 2025
ACLXSell300$80.00$24K−0.9%CHIEF MEDICAL OFFICER
Sep 18, 2025
ACLXSell3,343$80.01$267K−8.9%CHIEF MEDICAL OFFICER

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
ACLXArcellx, Inc.11$4.3M

Other insiders at Arcellx, Inc.

1 other tracked filer at ACLX.